AI Biotech Iambic Gets $150M in IPO Cash for ‘Molecular Superintelligence’ Drug R&D
Iambic Therapeutics, an AI-enabled biotech firm, will apply the IPO proceeds towards medical improvement of its pipeline of internally found ...
Iambic Therapeutics, an AI-enabled biotech firm, will apply the IPO proceeds towards medical improvement of its pipeline of internally found ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.